A Phase 1 Study of S-3304 in Patients With Solid Tumors
Phase 1
18 Years
85 Years
18 Years
85 Years
Open (Enrolling)
Both
Solid Tumors
Both
Solid Tumors
Trial Information
A Phase 1 Study of S-3304 in Patients With Solid Tumors
Inclusion Criteria
Inclusion criteria:
- Biopsy proven diagnosis of solid tumor(s) with biopsy accessible lesion(s)
- Must be able to tolerate oral medication Exclusion criteria
- Patients with other serious illnesses
- Patients who are receiving treatments
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Authority:
United States: Food and Drug Administration
Study ID:
0110P1416
NCT ID:
NCT00033215
Start Date:
November 2001
Completion Date:
October 2003
Related Keywords:
- Solid Tumors
- neovascularization
- matrix metalloproteinases
- antiangiogenesis
- type IV collagenases
- Neoplasms
Name | Location |
|---|---|
| Cleveland Clinic Foundation | Cleveland, Ohio 44195 |
| Rush-Presbyterian-St. Lukes Medical Center | Chicago, Illinois 60612 |
| University of Colorado Hospital | Denver, Colorado 80262 |
| Roswell Park Cancer Center | Buffalo, New York 14263 |
